S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GALT Galectin Therapeutics Inc

1.555

0.065 (4.36%)

Last Updated: 04:00:18

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics Inc News

Form 8-K - Current report
Tuesday 18 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

More Galectin Therapeutics Inc News Articles

VinaCapital Vietnam Oppo...

BNP Paribas Issuance

XS2858865384 20280911 23...

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions